Publication: Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord
Issued Date
2013-04-01
Resource Type
ISSN
14455994
14440903
14440903
Other identifier(s)
2-s2.0-84875667664
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Internal Medicine Journal. Vol.43, No.4 (2013), 430-439
Suggested Citation
S. Manochantr, Y. U-pratya, P. Kheolamai, S. Rojphisan, M. Chayosumrit, C. Tantrawatpan, A. Supokawej, S. Issaragrisil Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord. Internal Medicine Journal. Vol.43, No.4 (2013), 430-439. doi:10.1111/imj.12044 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/32416
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord
Other Contributor(s)
Abstract
Background: The role of bone marrow-derived mesenchymal stromal cells (BM-MSC) in preventing the incidence and ameliorating the severity of graft-versus-host disease (GvHD) has recently been reported. However, as the collection of BM-MSC is an invasive procedure, more accessible sources of MSC are desirable. Aim: This study aimed to explore the alternative sources of MSC from amnion, placenta, Wharton's jelly and umbilical cord, which are usually discarded. Methods: MSC from those tissues were isolated using mechanical dissociation and enzymatic digestion. Their capacity for proliferation and differentiation, and ability to suppress alloreactive T-lymphocytes were studied and compared with those of BM-MSC. Results: MSC derived from amnion, placenta, Wharton's jelly and umbilical cord were similar to BM-MSC regarding the cell morphology, the immunophenotype as well as the differentiation ability. These MSC also elicited a similar degree of immunosuppression, as evidenced by the inhibition of alloreactive T-lymphocytes in the mixed lymphocyte reaction, compared with that of BM-MSC. MSC from umbilical cord and Wharton's jelly had a higher proliferative capacity, whereas those from amnion and placenta had a lower proliferative capacity compared with BM-MSC. Conclusion: The results obtained from this study suggest that MSC from amnion, placenta, Wharton's jelly and umbilical cord can therefore be potentially used for substituting BM-MSC in several therapeutic applications, including the treatment of GvHD. © 2012 Royal Australasian College of Physicians.